Print-File

ESHO

European Society of Hyperthermic
Oncology

The European Society for Hyperthermic Oncology


The object of the European Society for Hyperthermic Oncology (ESHO) is to promote for the public benefit, fundamental and applied research in physics, engineering, biological and clinical sciences relating to the use of hyperthermia in cancer therapy.

Moreover, the society wants to facilitate integration and exchange of information between different disciplines in the study of the biological effects of heat in the treatment of cancer either alone or combined with other cancer treatment modalities.

The European Society for Hyperthermic Oncology was established in 1987 in England. In 1992, the registered office of the Society was transferred to The Netherlands.

Board members

  • Hans Crezee (The Netherlands)  - President
  • Pirus Ghadjar (Germany) - Vice-President
  • Lars Lindner (Germany) - Vice-President
  • Udo S. Gaipl (Germany)
  • Boguslaw Lindner (Poland)
  • Niloy R. Datta (India)
  • Arlene L. Oei (The Netherlands)
  • Hana Dobsicek Trefna (Sweden)
  • Gerard C van Rhoon/M. Willemijn Kolff (The Netherlands)

ESHO statutes and membership

ESHO STRATEGY PLAN 2020-2025